Elyxium Wealth’s Revolution Medicines RVMD Stock Holding History

Elyxium Wealth’s Portfolio RVMD Stock Details RVMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$53K	Buy	+258	New	+$51.1K	0.01%	596

Other funds holding RVMD

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Chicago Capital Chicago, Illinois $4.32B AUM 31.14% 1-Year Est. Return

Parnassus Investments San Francisco, California $33.8B AUM 31.08% 1-Year Est. Return

Loftus Peak Sydney, Australia $781M AUM

BI Asset Management Fondsmaeglerselskab Kobenhavn, Denmark $13.1B AUM 35.37% 1-Year Est. Return

Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return

Asset Management One Tokyo, Japan $40B AUM 30.45% 1-Year Est. Return

STRS Ohio Columbus, Ohio $27.1B AUM 34.64% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

Elyxium Wealth's RVMD Position: Q3 2026 in Review

Elyxium Wealth opened a new position in Revolution Medicines (RVMD) in Q3 2026: 258 shares worth $53K. The stake represents 0.01% of the portfolio and ranks #596 among its holdings.

224 funds tracked by Wall St. Rank hold RVMD as of Q3 2026.

Elyxium Wealth held 258 shares of Revolution Medicines worth $53K as of Q3 2026.
Revolution Medicines was a new Elyxium Wealth position in Q3 2026.
Revolution Medicines made up 0.01% of Elyxium Wealth's portfolio in Q3 2026, its #596 holding.
224 funds tracked by Wall St. Rank held Revolution Medicines as of Q3 2026.

Based on Elyxium Wealth's 13F filing for Q3 2026, filed 27 Oct 2026.